Back to search
FDAFDA · Food and drugs·Recall number D-524-2013

BroveX PSE, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737 NDC 58605-440-01

Published June 12, 2013 · Recall initiated: January 30, 2013

Summary

FDA records drug Class II recall D-524-2013, published June 12, 2013 and initiated January 30, 2013. Recalling firm: TG United, Inc.; Status: Terminated; Reported quantity: 10,036 bottles - 100-count tablets; Lot: Lot# 11A001 Exp. 12/12; Lot# 11L002 Exp. 10/13; Lot # 12K007 Exp. 09/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
TG United, Inc.
Distributor
FL, MS, SC, LA and TX
Lot
Lot# 11A001 Exp. 12/12; Lot# 11L002 Exp. 10/13; Lot # 12K007 Exp. 09/14.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BroveX PSE, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737 NDC 58605-440-01 recalled?

Yes. FDA published recall D-524-2013 on June 12, 2013. Reported hazard: CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

What should I do if I have this product?

Voluntary: Firm initiated · Letter